+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Dyslipidemia among HIV-infected patients

Dyslipidemia among HIV-infected patients

Annals of African Medicine 13(3): 142

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 052742271

Download citation: RISBibTeXText

PMID: 24923376

DOI: 10.4103/1596-3519.134424

Related references

Management of dyslipidemia in HIV-infected patients. Mmw Fortschritte der Medizin 154 Suppl 1: 34-36, 2012

Treatment of dyslipidemia in HIV-infected patients. Expert Opinion on PharmacoTherapy 11(11): 1845-1854, 2010

The evaluation and management of dyslipidemia in HIV-infected patients. Aids Clinical Care 13(12): 113-7, 120, 2002

Dyslipidemia and lipid management in HIV-infected patients. Current Opinion in Endocrinology, Diabetes, and Obesity 18(2): 144-147, 2011

Prevalence of dyslipidemia and dysglycaemia in HIV infected patients. East African Medical Journal 85(1): 10-17, 2008

Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection. Journal of Infection 50(4): 331-337, 2005

Cardiovascular risk and dyslipidemia management in HIV-infected patients. Topics in Antiviral Medicine 20(4): 129-33; Quiz 123-4, 2013

Dyslipidemia in HIV-infected patients A new population in coronary risk?. European Heart Journal 23(Abstract Supplement): 566, August-September, 2002

Lipid-lowering agents for dyslipidemia in patients who were infected with HIV in Taoyuan, Taiwan. Journal of the International Aids Society 17(4 Suppl 3): 19556, 2014

Efavirenz to nevirapine switch in HIV-1-infected patients with dyslipidemia: a randomized, controlled study. Clinical Infectious Diseases 45(2): 263-266, 2007

Improvement of lipid profiles when switching from efavirenz to rilpivirine in HIV-infected patients with dyslipidemia. HIV Clinical Trials 17(1): 12-16, 2016

Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy. Aids 27(4): 529-538, 2013

Management of dyslipidemia and other cardiovascular risk factors in HIV-infected patients: case-based review. Topics in HIV Medicine 14(4): 134-139, 2006

Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South African HIV-Infected Patients. Plos One 11(3): E0151911, 2016

Dyslipidemia in HIV-infected women on antiretroviral therapy Analysis of 922 patients from the Spanish VACH cohort. 2011